Compare Abeona Therapeutics Inc (ABEO) vs Aehr Test Systems (AEHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Aehr Test Systems — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Aehr Test Systems trades at $119.53 (market cap $3.82B). The key difference: Aehr Test Systems is far larger — about 9.1× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AEHR | |
|---|---|---|
Market Cap | $421.19M | $3.82B |
Sector | Health | Technology |
52-Week High | $7.45 | $117.18 |
52-Week Low | $4.17 | $17.38 |
Enterprise Value | $276.10M | $3.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →
